Mindray Medical Grows Revenues 14.5% in 2013

Mindray Medical, China’s largest medical device company, reported revenues climbed 14.5% to $1.2 billion during 2013, and net income was up 25% at $225 million (GAAP). Western European markets were especially strong, rising more than 20%. Mindray forecast that sales for 2014 would rise at least 15%, but non-GAAP net income will remain at 2013 levels. During 2014, the company expects to invest in sales, marketing and distribution as well as product innovation. More details.... Stock Symbol: (NYSE: MR) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.